OctPM pathway control state: Difference between revisions

From Bioblast
m (moved PMOct to OctPM)
No edit summary
Line 5: Line 5:
'''MitoPathway control:''' FAO<small>&</small>CI
'''MitoPathway control:''' FAO<small>&</small>CI


'''SUIT protocol:''' [[SUIT RP1]], [[SUIT RP1]]
'''SUIT protocol:''' [[SUIT_FNSGp(PGM)01]] - SUIT RP1, [[SUIT_FNSGp(PGM)02]] - SUIT RP1


This substrate combination supports CI-linked flux which is typically higher than FAO capacity. In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare [[Malate alone]], and pyruvate is added to compare FAO as the background state with CI&FAO as the reference state.
This substrate combination supports CI-linked flux which is typically higher than FAO capacity. In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare [[Malate alone]], and pyruvate is added to compare FAO as the background state with CI&FAO as the reference state.
Line 16: Line 16:


== OctPM(P) ==
== OctPM(P) ==
# [[SUIT RP2]]_'''4P''': 1D 2Oct 3Mtit 3c (3NADH) '''<u>4P</u>''' 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd'''
# [[SUIT_FNSGp(PGM)02]]_'''4P''': 1D 2Oct 3Mtit&Mc (&McNADH) '''<u>4P</u>''' 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd'''


== OctPM(E) ==
== OctPM(E) ==
# [[SUIT RP1]]_'''4Oct''': 1PM 2D 2c (2NADH) 3U '''<u>4Oct</u>''' 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd
# [[SUIT_FNSGp(PGM)01]]_'''4Oct''': 1PM 2D&Dc (&DcNADH) 3U '''<u>4Oct</u>''' 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd


----
----

Revision as of 07:07, 9 September 2016


high-resolution terminology - matching measurements at high-resolution


OctPM pathway control state

Description

OctPM: Octanoylcarnitine & Pyruvate & Malate.

MitoPathway control: FAO&CI

SUIT protocol: SUIT_FNSGp(PGM)01 - SUIT RP1, SUIT_FNSGp(PGM)02 - SUIT RP1

This substrate combination supports CI-linked flux which is typically higher than FAO capacity. In SUIT-RP1, PMOct is induced after PM(E), to evaluate any additive effect of adding Oct. In SUIT-RP2, FAO OXPHOS capacity is measured first, testing for the effect of increasing malate concentration (compare Malate alone, and pyruvate is added to compare FAO as the background state with CI&FAO as the reference state.

Abbreviation: PMOct

Reference: MiPNet21.06 SUIT reference protocol


MitoPedia concepts: Respiratory state, SUIT state 

OctPM(L)

OctPM(P)

  1. SUIT_FNSGp(PGM)02_4P: 1D 2Oct 3Mtit&Mc (&McNADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd

OctPM(E)

  1. SUIT_FNSGp(PGM)01_4Oct: 1PM 2D&Dc (&DcNADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd

SUIT RP1


SUIT RP2


Cookies help us deliver our services. By using our services, you agree to our use of cookies.